NO20014756L - C(10)-heterosubstituerte acetattaxaner som antitmormidler - Google Patents
C(10)-heterosubstituerte acetattaxaner som antitmormidlerInfo
- Publication number
- NO20014756L NO20014756L NO20014756A NO20014756A NO20014756L NO 20014756 L NO20014756 L NO 20014756L NO 20014756 A NO20014756 A NO 20014756A NO 20014756 A NO20014756 A NO 20014756A NO 20014756 L NO20014756 L NO 20014756L
- Authority
- NO
- Norway
- Prior art keywords
- hetero
- antithrombotic agents
- taxanes
- substituted acetate
- acetate taxanes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17966900P | 2000-02-02 | 2000-02-02 | |
| PCT/US2001/003553 WO2001056564A1 (en) | 2000-02-02 | 2001-02-02 | C10 heterosubstituted acetate taxanes as antitumor agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20014756D0 NO20014756D0 (no) | 2001-10-01 |
| NO20014756L true NO20014756L (no) | 2001-11-29 |
Family
ID=22657495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20014756A NO20014756L (no) | 2000-02-02 | 2001-10-01 | C(10)-heterosubstituerte acetattaxaner som antitmormidler |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US6664275B2 (hu) |
| EP (1) | EP1165068B1 (hu) |
| JP (1) | JP2003521514A (hu) |
| KR (1) | KR20020002488A (hu) |
| CN (1) | CN1362876A (hu) |
| AT (1) | ATE381328T1 (hu) |
| AU (1) | AU776767B2 (hu) |
| BR (1) | BR0104350A (hu) |
| CA (1) | CA2368502A1 (hu) |
| CZ (1) | CZ20013523A3 (hu) |
| DE (1) | DE60131927D1 (hu) |
| HK (1) | HK1047896A1 (hu) |
| HU (1) | HUP0200750A3 (hu) |
| IL (1) | IL145639A (hu) |
| MX (1) | MXPA01009924A (hu) |
| NO (1) | NO20014756L (hu) |
| NZ (1) | NZ514406A (hu) |
| PL (1) | PL350027A1 (hu) |
| TW (1) | TWI257390B (hu) |
| WO (1) | WO2001056564A1 (hu) |
| ZA (1) | ZA200108052B (hu) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003521514A (ja) * | 2000-02-02 | 2003-07-15 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | 抗腫瘍剤としてのｃ１０ヘテロ置換アセテートタキサン |
| JP2003521545A (ja) * | 2000-02-02 | 2003-07-15 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | 改良された溶解性を有するタキサン製剤 |
| KR20050032110A (ko) * | 2002-08-02 | 2005-04-06 | 이뮤노젠 아이엔씨 | 신규의 효능을 갖는 탁산을 포함하는 세포독성제 및 그치료용도 |
| US7390898B2 (en) | 2002-08-02 | 2008-06-24 | Immunogen Inc. | Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| EP1894921A3 (en) * | 2003-09-25 | 2008-03-12 | Tapestry Pharmaceuticals, Inc. | 9, 10-Alpha, Alpha-Oh-Taxane analogs and methods for production thereof |
| ATE377593T1 (de) | 2003-09-25 | 2007-11-15 | Tapestry Pharmaceuticals Inc | 9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung |
| CN1712399B (zh) * | 2004-06-24 | 2010-08-11 | 中国医学科学院药物研究所 | 紫杉醇和免疫增强剂胞壁酰二肽共轭物的制备及用途 |
| KR100627436B1 (ko) * | 2005-10-18 | 2006-09-22 | 주식회사 시드컴 | 차량용 요일체킹장치 |
| WO2008106621A1 (en) | 2007-02-28 | 2008-09-04 | Tapestry Pharmaceuticals, Inc | Taxane analogs for the treatment of brain cancer |
| US11786504B2 (en) | 2006-09-28 | 2023-10-17 | Tapestry Pharmaceuticals, Inc. | Taxane analogs for the treatment of brain cancer |
| WO2008121476A1 (en) | 2007-03-28 | 2008-10-09 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| US11873308B2 (en) | 2006-11-06 | 2024-01-16 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| US20080233135A1 (en) * | 2007-03-19 | 2008-09-25 | Gebhard John R | Cobalamin taxane bioconjugates |
| CA2721153C (en) * | 2008-04-10 | 2018-10-02 | Abraxis Bioscience, Llc | Compositions of hydrophobic taxane derivatives and uses thereof |
| KR20150136137A (ko) * | 2008-04-10 | 2015-12-04 | 아브락시스 바이오사이언스, 엘엘씨 | 소수성 탁산 유도체의 조성물 및 그의 용도 |
| CN102740976B (zh) | 2010-01-29 | 2016-04-20 | 精密公司 | 取样-应答微流体盒 |
| EP3239139B1 (en) | 2010-05-27 | 2020-10-28 | Ningbo Combireg Pharmaceutical Technology Co. Ltd | Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate |
| KR20150097764A (ko) | 2012-12-21 | 2015-08-26 | 마이크로닉스 인코포레이티드. | 휴대형 형광 검출 시스템 및 미량분석 카트리지 |
| WO2014100732A1 (en) | 2012-12-21 | 2014-06-26 | Micronics, Inc. | Fluidic circuits and related manufacturing methods |
| EP3549674B1 (en) | 2012-12-21 | 2020-08-12 | PerkinElmer Health Sciences, Inc. | Low elasticity films for microfluidic use |
| WO2014182847A1 (en) | 2013-05-07 | 2014-11-13 | Micronics, Inc. | Device for preparation and analysis of nucleic acids |
| WO2014182831A1 (en) | 2013-05-07 | 2014-11-13 | Micronics, Inc. | Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions |
| US10386377B2 (en) | 2013-05-07 | 2019-08-20 | Micronics, Inc. | Microfluidic devices and methods for performing serum separation and blood cross-matching |
| EP3516401A1 (en) | 2016-09-19 | 2019-07-31 | Genmark Diagnostics Inc. | Instrument for processing cartridge for performing assays in a closed sample preparation and reaction system |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960790A (en) | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
| US5175315A (en) | 1989-05-31 | 1992-12-29 | Florida State University | Method for preparation of taxol using β-lactam |
| US5283253A (en) | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| US5721268A (en) | 1991-09-23 | 1998-02-24 | Florida State University | C7 taxane derivatives and pharmaceutical compositions containing them |
| US5714513A (en) | 1991-09-23 | 1998-02-03 | Florida State University | C10 taxane derivatives and pharmaceutical compositions |
| US5243045A (en) | 1991-09-23 | 1993-09-07 | Florida State University | Certain alkoxy substituted taxanes and pharmaceutical compositions containing them |
| US5350866A (en) | 1991-09-23 | 1994-09-27 | Bristol-Myers Squibb Company | 10-desacetoxytaxol derivatives |
| US5430160A (en) | 1991-09-23 | 1995-07-04 | Florida State University | Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides |
| US5227400A (en) | 1991-09-23 | 1993-07-13 | Florida State University | Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them |
| DE69333675T2 (de) | 1992-01-15 | 2006-02-02 | E.R. Squibb & Sons, Inc. | Enzymatische Verfahren zur Trennung von Enantiomerengemischen von Verbindungen, die als Zwischenprodukte zur Herstellung von Taxanen nützlich sind |
| US5272171A (en) | 1992-02-13 | 1993-12-21 | Bristol-Myers Squibb Company | Phosphonooxy and carbonate derivatives of taxol |
| US5939561A (en) | 1992-03-10 | 1999-08-17 | Rhone-Poulence Rorer S.A. | Process for the preparation of β-phenylisoserine and β-lactam and their analogues |
| US5200534A (en) | 1992-03-13 | 1993-04-06 | University Of Florida | Process for the preparation of taxol and 10-deacetyltaxol |
| FR2702212B1 (fr) | 1993-03-02 | 1995-04-07 | Rhone Poulenc Rorer Sa | Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
| US5703247A (en) | 1993-03-11 | 1997-12-30 | Virginia Tech Intellectual Properties, Inc. | 2-Debenzoyl-2-acyl taxol derivatives and methods for making same |
| ATE249448T1 (de) | 1993-06-11 | 2003-09-15 | Upjohn Co | Delta 6,7-taxol derivate antineoplastische verbindungen und diese enthaltende pharmazeutische zusammenstellungen |
| IL109926A (en) | 1993-06-15 | 2000-02-29 | Bristol Myers Squibb Co | Methods for the preparation of taxanes and microorganisms and enzymes utilized therein |
| TW397866B (en) | 1993-07-14 | 2000-07-11 | Bristol Myers Squibb Co | Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes |
| FR2711369B1 (fr) | 1993-10-20 | 1995-11-17 | Rhone Poulenc Rorer Sa | Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent. |
| WO1996013495A1 (en) | 1994-10-28 | 1996-05-09 | The Research Foundation Of State University Of New York | Taxoid derivatives, their preparation and their use as antitumor agents |
| MA23823A1 (fr) | 1995-03-27 | 1996-10-01 | Aventis Pharma Sa | Nouveaux taxoides, leur preparation et les compositions qui les contiennent |
| US5780653A (en) | 1995-06-07 | 1998-07-14 | Vivorx Pharmaceuticals, Inc. | Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers |
| CA2231837A1 (en) | 1995-09-13 | 1997-03-20 | Florida State University | Radiosensitizing taxanes and their pharmaceutical preparations |
| TW338042B (en) * | 1995-10-31 | 1998-08-11 | Clary Kk | Process for producing all trans-form polyprenols |
| US5756536A (en) | 1995-11-03 | 1998-05-26 | Purdue Research Foundation | Microbial transformation of taxol and cephalomannine |
| US5899043A (en) * | 1995-12-18 | 1999-05-04 | Engineering Certifiers Ltd. | Ductile-failure anchors for concrete elements |
| US5767297A (en) * | 1997-02-05 | 1998-06-16 | Ensuiko Sugar Refining Co., Ltd. | Taxoid derivative and method of producing thereof |
| WO1997042181A1 (en) | 1996-05-06 | 1997-11-13 | Florida State University | 1-deoxy baccatin iii, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof |
| EP0930309A4 (en) * | 1996-07-15 | 2001-09-26 | Yakult Honsha Kk | TAXANE DERIVATIVES AND MEDICINES CONTAINING THEM |
| US5811452A (en) | 1997-01-08 | 1998-09-22 | The Research Foundation Of State University Of New York | Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof |
| US5912264A (en) | 1997-03-03 | 1999-06-15 | Bristol-Myers Squibb Company | 6-halo-or nitrate-substituted paclitaxels |
| HU224589B1 (hu) | 1997-06-03 | 2005-11-28 | Ensuiko Sugar Refining Co., Ltd. | Taxoidszármazékok és eljárás előállításukra |
| SE9702776D0 (sv) * | 1997-07-22 | 1997-07-22 | Pharmacia & Upjohn Ab | Method of preparing pharmaceutical compositions |
| US7288665B1 (en) | 1997-08-18 | 2007-10-30 | Florida State University | Process for selective derivatization of taxanes |
| JP2003521514A (ja) * | 2000-02-02 | 2003-07-15 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | 抗腫瘍剤としてのｃ１０ヘテロ置換アセテートタキサン |
| BR0104358A (pt) | 2000-02-02 | 2002-01-02 | Univ Florida State Res Found | Formulações de taxana tendo solubilidade aperfeiçoada |
-
2001
- 2001-02-02 JP JP2001556255A patent/JP2003521514A/ja not_active Withdrawn
- 2001-02-02 DE DE60131927T patent/DE60131927D1/de not_active Expired - Lifetime
- 2001-02-02 NZ NZ514406A patent/NZ514406A/en unknown
- 2001-02-02 IL IL145639A patent/IL145639A/en not_active IP Right Cessation
- 2001-02-02 KR KR1020017012585A patent/KR20020002488A/ko active IP Right Grant
- 2001-02-02 HU HU0200750A patent/HUP0200750A3/hu unknown
- 2001-02-02 CA CA002368502A patent/CA2368502A1/en not_active Abandoned
- 2001-02-02 WO PCT/US2001/003553 patent/WO2001056564A1/en active IP Right Grant
- 2001-02-02 AT AT01906951T patent/ATE381328T1/de not_active IP Right Cessation
- 2001-02-02 EP EP01906951A patent/EP1165068B1/en not_active Expired - Lifetime
- 2001-02-02 BR BR0104350-1A patent/BR0104350A/pt not_active IP Right Cessation
- 2001-02-02 PL PL01350027A patent/PL350027A1/xx not_active Application Discontinuation
- 2001-02-02 MX MXPA01009924A patent/MXPA01009924A/es active IP Right Grant
- 2001-02-02 CN CN01800315A patent/CN1362876A/zh active Pending
- 2001-02-02 CZ CZ20013523A patent/CZ20013523A3/cs unknown
- 2001-02-02 US US09/775,912 patent/US6664275B2/en not_active Expired - Fee Related
- 2001-02-02 AU AU34792/01A patent/AU776767B2/en not_active Ceased
- 2001-03-27 TW TW090102213A patent/TWI257390B/zh not_active IP Right Cessation
- 2001-10-01 ZA ZA200108052A patent/ZA200108052B/en unknown
- 2001-10-01 NO NO20014756A patent/NO20014756L/no not_active Application Discontinuation
-
2003
- 2003-01-07 HK HK03100167.4A patent/HK1047896A1/zh unknown
- 2003-06-27 US US10/609,301 patent/US6872837B2/en not_active Expired - Fee Related
-
2005
- 2005-02-28 US US11/068,166 patent/US7157474B2/en not_active Expired - Fee Related
-
2006
- 2006-12-04 US US11/566,439 patent/US20070249707A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PL350027A1 (en) | 2002-10-21 |
| IL145639A (en) | 2007-02-11 |
| NO20014756D0 (no) | 2001-10-01 |
| WO2001056564A1 (en) | 2001-08-09 |
| KR20020002488A (ko) | 2002-01-09 |
| TWI257390B (en) | 2006-07-01 |
| US20020068755A1 (en) | 2002-06-06 |
| EP1165068A1 (en) | 2002-01-02 |
| CN1362876A (zh) | 2002-08-07 |
| IL145639A0 (en) | 2002-06-30 |
| AU3479201A (en) | 2001-08-14 |
| HUP0200750A3 (en) | 2005-02-28 |
| US20050143447A1 (en) | 2005-06-30 |
| DE60131927D1 (de) | 2008-01-31 |
| HUP0200750A2 (hu) | 2002-07-29 |
| US20070249707A1 (en) | 2007-10-25 |
| NZ514406A (en) | 2005-01-28 |
| CA2368502A1 (en) | 2001-08-09 |
| MXPA01009924A (es) | 2003-08-01 |
| EP1165068B1 (en) | 2007-12-19 |
| US20040024051A1 (en) | 2004-02-05 |
| ZA200108052B (en) | 2003-12-01 |
| US6664275B2 (en) | 2003-12-16 |
| AU776767B2 (en) | 2004-09-23 |
| US6872837B2 (en) | 2005-03-29 |
| HK1047896A1 (zh) | 2003-03-14 |
| CZ20013523A3 (cs) | 2002-03-13 |
| ATE381328T1 (de) | 2008-01-15 |
| JP2003521514A (ja) | 2003-07-15 |
| BR0104350A (pt) | 2002-01-02 |
| US7157474B2 (en) | 2007-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20014756L (no) | C(10)-heterosubstituerte acetattaxaner som antitmormidler | |
| DK1131315T3 (da) | Polyhydroxylerede heterocykliske derivater som antikoagulanter | |
| NO20034660D0 (no) | Spiropyrazolforbindelser | |
| PT1109812E (pt) | Pirrolobenzodiazepinas | |
| BG105967A (en) | C(7) ester substituted taxanes and their use as antitumor agents | |
| NO20014758D0 (no) | C(7)-heterosubstituerte acetattaksaner som antitumormidler | |
| DE60128100D1 (de) | Analgetisches arzneimittel | |
| DK0842165T3 (da) | Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler | |
| BG105964A (en) | C(10) carbonate substituted taxanes and their use as antitumor agents | |
| NO20014754D0 (no) | C(10)-estersubstituerte taksaner som antitumormidler | |
| DE60134814D1 (de) | C10-carbamoyloxysubstituierte taxane als antitumormittel | |
| NO20014757D0 (no) | C(7)-karbamoyloksysubstituerte taksaner som antitumormidler | |
| ATE282611T1 (de) | Stolonoxide | |
| DK1119351T3 (da) | Anvendelse af katecholderivater som proteinaseinhibitorer | |
| RS50412B (sr) | Derivati tiazofurina | |
| SG125888A1 (en) | C10 carbonate substituted taxanes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |